Galapagos NV
GLPG
#4563
Rank
โ‚ฌ1.81 B
Marketcap
27,13ย โ‚ฌ
Share price
-0.57%
Change (1 day)
6.57%
Change (1 year)

Galapagos NV (GLPG) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ3.53 Billion

According to Galapagos NV's latest financial reports the company's total assets are โ‚ฌ3.53 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Galapagos NV - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ4.13 B-5.09%
2023-12-31โ‚ฌ4.35 B-7.96%
2022-12-31โ‚ฌ4.73 B-8.83%
2021-12-31โ‚ฌ5.19 B-9.17%
2020-12-31โ‚ฌ5.71 B-5.78%
2019-12-31โ‚ฌ6.06 B321.58%
2018-12-31โ‚ฌ1.43 B11.91%
2017-12-31โ‚ฌ1.28 B18.73%
2016-12-31โ‚ฌ1.08 B144.81%
2015-12-31โ‚ฌ0.44 B63.61%
2014-12-31โ‚ฌ0.27 B-5.88%
2013-12-31โ‚ฌ0.28 B22.12%
2012-12-31โ‚ฌ0.23 B46.12%
2011-12-31โ‚ฌ0.16 B-16.97%
2010-12-31โ‚ฌ0.19 B34.97%
2009-12-31โ‚ฌ0.14 B20.94%
2008-12-31โ‚ฌ0.11 B-20.1%
2007-12-31โ‚ฌ0.14 B-11.29%
2006-12-31โ‚ฌ0.16 B105.54%
2005-12-31โ‚ฌ81.56 M422.4%
2004-12-31โ‚ฌ15.61 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AstraZeneca
AZN
โ‚ฌ98.30 B 2,677.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚ฌ165.60 B 4,578.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ130.83 B 3,595.81%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚ฌ115.00 B 3,148.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
โ‚ฌ0.13 B-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ72.30 B 1,942.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ34.23 B 867.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚ฌ70.82 B 1,900.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ111.26 B 3,043.15%๐Ÿ‡บ๐Ÿ‡ธ USA